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Denys-Drash syndrome (DOS) is a rare developmental disorder 
of the genifo..uriruuy system characterized by severe nephropathy, 
genital abnormalities and a predisposition to Wilms' tumor 
(Denys, 1967, Drash, 1970). All components of the syndrome 
appear to be caused by dominant mutations of the Wll Wilms' 
tumor gene (Pelletieret al., 1991). WTl has first been identified 
as a tumor suppressor gene that is deleted or inactivated in a 
certain fraction of Wilms' tumors (Call et al. , 1990; Gessler et 
al., 1990). The gene encodes a DNA-binding zinc finger protein 
tbat can regulate transcription of other genes (Rauscher et al., 
1990). 
The majority of WTJ mutations detected in DOS patients are 
highly specific point mutations that alter DNA contact sites within 
the zinc finger domain of the WI'l protein (Pelletier et al. , 1991). 
More recently, some cases were described where the WTJ 
mutations would result in a truncated WTJ proteinthat is missing 
all or part of the zinc finger domain (Baird et al., 1992; Little 
et al. , 1993; Ogawa et al. , 1993). These observations favor the 
interpretation of DOS mutations as dominant negative mutations 
where a shortened WTJ polypeptide competes with wild-type 
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effector sites. 
A single case, patient C.S., described by Bruening et al. 
(1992), however, suggested that even alterations in the balance 
between altematively spliced forms of WTJ may be sufficient 
to generate DOS. There are two sites of alternative splicing in 
the WTJ gene (Haber et al., 1991; Gessler et al., 1992). The 
first, leading to the presence or absence of exon 5 has not been 
associated with a functional correlate. The second site is found 
at the end of exon 9 where two splice donor sites, located within 
9 basepairs, can be used, resulting in the insertion of 3 amino 
acids ( + KTS) between zinc fingers 3 and 4 with concomitant 
changes in the DNA binding characteristics of the resulting zinc 
fingers (Rauscher et al., 1990; Bickmore et al., 1992). The 
relative ratio of the different WTJ isoforms appears constant in 
aU cases examined with the longer products being more abundant. 
Here, we describe a new case of DDS, patient J.A., where 
a mutation in one of the splice donor sites of exon 9, identical 
to the one described in patient C.S., has been found supporting 
the concept that the balance of WTJ isofonns is critical for normal 
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Flpre 1. a) SSCP analysis of exon 9 in patient J.A. (laDe I) and two control DNAs (2, 3). PCR amplifk:ation from wbit.e blood cell ONA and denawration of 
radiolabeled products were done as described (Poulat er aJ., 1993). Sampies were separated on a 6«Ai potyacrylamide gd at 30 Wand 4°C, foUowed by dJying 
and autaradio&raphy. Tbc arrow l1l8Jb the location of the ncw band detccted in patient J.A. b) For dircct scquenoe analysis exon 9 was IUDJ>!ificd from genomic 
ONA and purified using Magie DNA Cleanup (Prornega). 1be 248 bp fragmentwas sequenced from both ends by Taq cycle sequencing using 32P-labeUed primers 
(fmol kit, Promcp). Tbe double band G/A (sense strand) and T/C (antisense strand) was not seeu in sc.qucnces from oontrol ONAs. c) scquenoe of the uou/intron 
junction. Boch a!temative splice sites (I and li) are shown with thc mutation site marbd by an asterisk. 
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development. Patient J.A. was suspected to have DOSbasedon 
clinical criteria. J.A. is a 13 year old female child with 
inconspicuous family history. Renal insufficiency was observed 
from the age of 2 years on. Chronic glomerulonephritis made 
dialysis necessary from the age of 8 years on and Jed to renal 
transplantation at 11.5 years. The girl was growth retarded and 
showed primary amenorrhea. External genitalia were normal 
female with endocrinological investigations revealing a 
hypergonadotrophic hypogonadism. The cytogenetic examination 
of peripheral blood lymphocytes showed a normal male 
karyotype. The combination of gonadal dysgenesis and chronic 
renal failure resulting from glomerular disease suggested the 
diagnosis of DOS. 
Because of the increased risk of malignancy gonads were 
removed. At laparotomy, uterus, Fallopian tubes and streak 
gonads were observed. Histologie examination showed normal 
Fallopian rubes, a ductus epididymis and dysgenetic gonadal tissue 
without typical testicular structures. The analysis of fibrobJast 
cultures from the streak gonads also revealed a normal male 
karyotype. The clinical picture with Müllerian structures present 
suggests that the AMH-producing fetal cells must have 
degenerated early. On the other band, testosteron-producing 
Leydig cells must also have been active for some time, as a ductus 
epid.idymis was present. 
During initial mo1ecular studies a deletion of the Y chromosome 
was not detected by PCR-studies employing primer pairs of the 
foUowing loci: PABY, SRY, ZFY, DYSI9, DYS14, alpha-
satellite, DXYS19, and DYZL (data not shown). 
To search for possible alterations of WTJ in this patient the 
coding region of the gene was assayed by SSCP analysis (Orita 
et al. , 1989). Only in exon 9 a slight alteration of the bands could 
be detected. The incomplete separation ofthe variant band from 
tbe normal band precluded direct analysis of the altered fragment. 
Exon 9 was therefore amplified from genomic DNA and 
sequenced directly from both ends. A single alteration could be 
detected in repeated sequencing reactions resulting in a G- A 
transversion in intron 9, five basepairs downstream the splice 
donor site (Figure 1). This is the same mutation as described 
in DOSpatient C.S. by Bruening et al. (1992). These authors 
have shown by transfection of minigene constructs containing 
WT1 exons 9 and 10 that this alteration abolishes the use of the 
second alternative splice donor site at exon 9. Thus, the Ionger 
+ KTS isoform of the WT1 protein can only be produced from 
the remaining nonnal allele, leading to an altered balance between 
these protein isoforms. The independent finding of the same kind 
of splicing mutant in a second patient with DOS provieles 
additional evidence that the precise ratio of different WT1 
isoforms may be critical during certain steps of kidney and 
gonadal development. 
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